# Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients

> **NCT07728318** · NA · NOT_YET_RECRUITING · sponsor: **Akhtar Saeed Medical and Dental College** · enrollment: 52 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight

## Interventions

- **OTHER:** Tirzepatide + Standard Therapy (Intervention Group)
- **OTHER:** Standard Oral Antidiabetic Drugs (OADs)

## Key facts

- **NCT ID:** NCT07728318
- **Lead sponsor:** Akhtar Saeed Medical and Dental College
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-12
- **Primary completion:** 2027-01-12
- **Final completion:** 2027-05-12
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2026-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07728318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07728318, "Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07728318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*